FOXO Technologies Inc. (NYSEAMERICAN:FOXO) Short Interest Update

FOXO Technologies Inc. (NYSEAMERICAN:FOXO) was the recipient of a significant increase in short interest during the month of February. As of February 28th, there was short interest totalling 1,890,000 shares, an increase of 111.0% from the February 13th total of 895,600 shares. Based on an average trading volume of 6,960,000 shares, the short-interest ratio is currently 0.3 days. Currently, 6.7% of the shares of the stock are short sold.

FOXO Technologies Trading Up 1.4 %

NYSEAMERICAN FOXO opened at $0.16 on Friday. The business’s fifty day moving average is $0.28. FOXO Technologies has a fifty-two week low of $0.13 and a fifty-two week high of $1.30.

Hedge Funds Weigh In On FOXO Technologies

An institutional investor recently bought a new position in FOXO Technologies stock. Jane Street Group LLC purchased a new position in shares of FOXO Technologies Inc. (NYSEAMERICAN:FOXO) during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund purchased 117,047 shares of the company’s stock, valued at approximately $34,000. Jane Street Group LLC owned 0.67% of FOXO Technologies as of its most recent filing with the Securities and Exchange Commission (SEC). 44.89% of the stock is owned by institutional investors and hedge funds.

About FOXO Technologies

FOXO Technologies Inc engages in epigenetic biomarker underwriting technology and consumer engagement platform service business in the United States. It operates through two segments, FOXO Labs and FOXO Life. The company applies automated machine learning and artificial intelligence technologies to discover epigenetic biomarkers of human health, wellness, and aging.